ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for MIRM

Stock NameMirum Pharmaceuticals Inc
TickerMIRM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS6047491013

Show aggregate MIRM holdings

News associated with MIRM

Brokerages Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Target Price at $74.44
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) has been assigned a consensus recommendation of “Buy” from the nine ratings firms that are covering the stock, Marketbeat reports. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price […] - 2025-09-19 02:26:46
Mirum Pharmaceuticals (NASDAQ:MIRM) Lowered to Buy Rating by Wall Street Zen
Wall Street Zen lowered shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) from a strong-buy rating to a buy rating in a research note released on Monday morning. Other analysts have also recently issued research reports about the stock. Raymond James Financial reissued a “strong-buy” rating on shares of Mirum Pharmaceuticals in a research note […] - 2025-08-26 03:03:11
Wall Street Zen Upgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Strong-Buy
Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Sunday. A number of other equities analysts also recently weighed in on the stock. JMP Securities set a $81.00 target price […] - 2025-08-19 02:58:52
Deutsche Bank AG Buys 71,421 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Deutsche Bank AG grew its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 42.2% during the first quarter, Holdings Channel reports. The firm owned 240,744 shares of the company’s stock after purchasing an additional 71,421 shares during the period. Deutsche Bank AG’s holdings in Mirum Pharmaceuticals were worth $10,846,000 as of its most […] - 2025-08-15 05:22:53
Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) from a hold rating to a buy rating in a research report released on Saturday morning. Several other research analysts have also commented on the stock. HC Wainwright raised their price objective on shares of Mirum Pharmaceuticals from $73.00 to $80.00 and gave […] - 2025-08-12 04:48:59
Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Up 9.1% on Analyst Upgrade
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) were up 9.1% during trading on Monday after Wall Street Zen upgraded the stock from a hold rating to a buy rating. The stock traded as high as $65.31 and last traded at $65.41. Approximately 671,423 shares traded hands during mid-day trading, an increase of […] - 2025-08-12 02:18:51
Zurcher Kantonalbank Zurich Cantonalbank Boosts Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 3.8% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 10,998 shares of the company’s stock after purchasing an additional 398 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Mirum Pharmaceuticals were worth $495,000 […] - 2025-08-08 04:48:50
Cwm LLC Boosts Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Cwm LLC boosted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 259.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 593 shares of the company’s stock after buying an additional 428 shares during the quarter. Cwm LLC’s holdings in Mirum Pharmaceuticals were worth $27,000 at the end of the most […] - 2025-08-06 04:24:52
Bank of New York Mellon Corp Buys 122,402 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Bank of New York Mellon Corp boosted its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 98.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 246,730 shares of the company’s stock after purchasing an additional 122,402 shares during the […] - 2025-07-21 04:26:48
Allspring Global Investments Holdings LLC Sells 1,195 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Allspring Global Investments Holdings LLC cut its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 12.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,786 shares of the company’s stock after selling 1,195 shares during the period. Allspring […] - 2025-07-11 04:36:57
KBC Group NV Makes New $89,000 Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
KBC Group NV acquired a new position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,967 shares of the company’s stock, valued at approximately $89,000. Other hedge funds have also added to or […] - 2025-07-08 04:42:53
Mirum Pharmaceuticals (NASDAQ:MIRM) Lowered to Hold Rating by Wall Street Zen
Wall Street Zen downgraded shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) from a buy rating to a hold rating in a research note published on Sunday morning. MIRM has been the topic of a number of other reports. HC Wainwright reiterated a “buy” rating and set a $73.00 price objective on shares of Mirum […] - 2025-07-07 03:22:59
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $60.73 Consensus Target Price from Analysts
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) has earned a consensus recommendation of “Buy” from the twelve ratings firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price […] - 2025-06-11 02:22:45
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 16.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 73,888 shares of the company’s stock after acquiring an additional […] - 2025-06-06 04:42:48
ProShare Advisors LLC Grows Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
ProShare Advisors LLC grew its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 31.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,457 shares of the company’s stock after acquiring an additional 3,227 shares during […] - 2025-05-26 06:09:07
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $1.01 Million Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lowered its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 24,327 shares of the company’s stock after selling 498 shares during the quarter. MIRAE […] - 2025-05-26 04:38:55
Nuveen Asset Management LLC Has $29.86 Million Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Nuveen Asset Management LLC boosted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 46.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 722,155 shares of the company’s stock after buying an additional 229,746 shares during the quarter. Nuveen Asset Management LLC’s holdings in Mirum Pharmaceuticals were worth $29,861,000 as of […] - 2025-05-22 06:38:53
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Bought by Millennium Management LLC
Millennium Management LLC grew its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 15.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 526,974 shares of the company’s stock after acquiring an additional 71,410 shares during the quarter. Millennium Management LLC owned about 1.10% […] - 2025-05-21 05:46:51
HC Wainwright Reiterates Buy Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)
Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research note issued to investors on Monday, Marketbeat.com reports. They currently have a $73.00 price objective on the stock. HC Wainwright’s price objective points to a potential upside of 61.01% from the company’s current price. […] - 2025-05-21 03:03:17
Comerica Bank Decreases Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Comerica Bank lessened its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 76.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 617 shares of the company’s stock after selling 1,971 shares during the period. Comerica Bank’s […] - 2025-05-20 04:28:52
Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) PT at $58.20
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have been given an average recommendation of “Buy” by the eleven ratings firms that are covering the stock, Marketbeat reports. Ten research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […] - 2025-04-22 02:34:59
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $58.20 Consensus Target Price from Analysts
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have earned a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, MarketBeat reports. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price […] - 2025-03-28 03:34:46
AlphaQuest LLC Grows Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
AlphaQuest LLC increased its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 969.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,829 shares of the company’s stock after acquiring an additional 1,658 shares during the quarter. AlphaQuest LLC’s holdings in […] - 2025-03-20 06:04:50
Bank of New York Mellon Corp Has $5.14 Million Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Bank of New York Mellon Corp grew its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 8.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 124,328 shares of the company’s stock after acquiring an additional 9,629 shares during the period. Bank of New York Mellon Corp’s holdings in Mirum Pharmaceuticals were […] - 2025-03-18 05:09:03
Empowered Funds LLC Invests $1.38 Million in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Empowered Funds LLC acquired a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 33,266 shares of the company’s stock, valued at approximately $1,376,000. A number of other large investors […] - 2025-02-17 06:16:48
Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $57.10
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have received a consensus rating of “Buy” from the eleven ratings firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […] - 2025-02-06 04:24:49

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc MIRM holdings

DateNumber of MIRM Shares HeldBase Market Value of MIRM SharesLocal Market Value of MIRM SharesChange in MIRM Shares HeldChange in MIRM Base ValueCurrent Price per MIRM Share HeldPrevious Price per MIRM Share Held
2025-12-11 (Thursday)4,220USD 277,338MIRM holding increased by 4431USD 277,3380USD 4,431 USD 65.7199 USD 64.6699
2025-12-10 (Wednesday)4,220USD 272,907MIRM holding decreased by -3081USD 272,9070USD -3,081 USD 64.6699 USD 65.4
2025-12-09 (Tuesday)4,220USD 275,988MIRM holding decreased by -10550USD 275,9880USD -10,550 USD 65.4 USD 67.9
2025-12-08 (Monday)4,220USD 286,538MIRM holding decreased by -2448USD 286,5380USD -2,448 USD 67.9 USD 68.4801
2025-12-05 (Friday)4,220USD 288,986MIRM holding decreased by -12871USD 288,9860USD -12,871 USD 68.4801 USD 71.5301
2025-12-04 (Thursday)4,220USD 301,857MIRM holding increased by 2279USD 301,8570USD 2,279 USD 71.5301 USD 70.99
2025-12-03 (Wednesday)4,220MIRM holding decreased by -70USD 299,578MIRM holding decreased by -207USD 299,578-70USD -207 USD 70.99 USD 69.88
2025-12-02 (Tuesday)4,290MIRM holding increased by 28USD 299,785MIRM holding increased by 1402USD 299,78528USD 1,402 USD 69.88 USD 70.0101
2025-12-01 (Monday)4,262USD 298,383MIRM holding decreased by -12956USD 298,3830USD -12,956 USD 70.0101 USD 73.05
2025-11-28 (Friday)4,262USD 311,339MIRM holding decreased by -341USD 311,3390USD -341 USD 73.05 USD 73.13
2025-11-27 (Thursday)4,262USD 311,680USD 311,6800USD 0 USD 73.13 USD 73.13
2025-11-26 (Wednesday)4,262USD 311,680MIRM holding increased by 5839USD 311,6800USD 5,839 USD 73.13 USD 71.76
2025-11-25 (Tuesday)4,262MIRM holding decreased by -42USD 305,841MIRM holding decreased by -4908USD 305,841-42USD -4,908 USD 71.76 USD 72.2
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MIRM by Blackrock for IE00B3VWM098

Show aggregate share trades of MIRM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03SELL-7071.81569.973 70.157USD -4,911 51.30 Loss of -1,320 on sale
2025-12-02BUY2871.54068.702 68.986USD 1,932 51.21
2025-11-25SELL-4273.35071.330 71.532USD -3,004 50.70 Loss of -875 on sale
2025-11-24SELL-4273.96070.620 70.954USD -2,980 50.59 Loss of -855 on sale
2025-11-17SELL-15472.98071.090 71.279USD -10,977 50.08 Loss of -3,265 on sale
2025-11-12SELL-1474.46570.110 70.546USD -988 49.77 Loss of -291 on sale
2025-11-06SELL-1470.33067.425 67.716USD -948 49.36 Loss of -257 on sale
2025-11-05SELL-14074.00068.105 68.695USD -9,617 49.25 Loss of -2,722 on sale
2025-11-04SELL-2872.62069.745 70.033USD -1,961 49.14 Loss of -585 on sale
2025-11-03SELL-2872.97568.710 69.136USD -1,936 49.03 Loss of -563 on sale
2025-10-28BUY4270.51071.790 71.662USD 3,010 48.54
2025-10-24SELL-1470.02070.640 70.578USD -988 48.30 Loss of -312 on sale
2025-10-15BUY8476.19076.405 76.383USD 6,416 47.35
2025-10-02BUY1471.75072.980 72.857USD 1,020 47.06
2025-09-30BUY2873.31074.728 74.586USD 2,088 46.76
2025-08-21SELL-1069.06069.130 69.123USD -691 45.99 Loss of -231 on sale
2025-07-31BUY3051.68052.595 52.504USD 1,575 45.83
2025-06-30SELL-2050.89051.930 51.826USD -1,037 45.10 Loss of -134 on sale
2025-06-25SELL-1050.13051.050 50.958USD -510 44.99 Loss of -60 on sale
2025-06-20SELL-2050.34051.280 51.186USD -1,024 44.87 Loss of -126 on sale
2025-05-23BUY1044.00044.100 44.090USD 441 44.54
2025-05-19SELL-1044.89045.700 45.619USD -456 44.54 Loss of -11 on sale
2025-05-15SELL-3045.28045.340 45.334USD -1,360 44.53 Loss of -24 on sale
2025-05-12SELL-1045.57046.230 46.164USD -462 44.51 Loss of -17 on sale
2025-05-09SELL-1044.27046.785 46.533USD -465 44.51 Loss of -20 on sale
2025-04-30SELL-1043.45043.680 43.657USD -437 44.60 Profit of 9 on sale
2025-04-24SELL-2040.47040.830 40.794USD -816 44.74 Profit of 79 on sale
2025-04-17SELL-1039.10039.450 39.415USD -394 45.04 Profit of 56 on sale
2025-04-15SELL-3038.63040.320 40.151USD -1,205 45.17 Profit of 151 on sale
2025-04-14SELL-3039.59040.050 40.004USD -1,200 45.24 Profit of 157 on sale
2025-04-09SELL-4041.47042.455 42.357USD -1,694 45.41 Profit of 122 on sale
2025-04-07SELL-7041.00043.220 42.998USD -3,010 45.53 Profit of 178 on sale
2025-04-04SELL-10042.03043.033 42.933USD -4,293 45.58 Profit of 264 on sale
2025-03-31BUY1045.05045.710 45.644USD 456 45.61
2025-03-19SELL-2047.13047.655 47.602USD -952 45.48 Loss of -42 on sale
2025-03-14SELL-6044.28045.900 45.738USD -2,744 45.52 Loss of -13 on sale
2025-03-13SELL-2044.56045.715 45.600USD -912 45.53 Loss of -1 on sale
2025-03-12SELL-34045.03046.020 45.921USD -15,613 45.54 Loss of -130 on sale
2025-03-07SELL-2043.46044.240 44.162USD -883 45.63 Profit of 29 on sale
2025-03-06SELL-3043.42044.435 44.334USD -1,330 45.66 Profit of 40 on sale
2025-03-03SELL-1045.99047.929 47.735USD -477 45.68 Loss of -21 on sale
2025-02-28SELL-6047.57047.990 47.948USD -2,877 45.65 Loss of -138 on sale
2025-02-26SELL-1050.52051.750 51.627USD -516 45.55 Loss of -61 on sale
2025-02-25SELL-3049.93051.740 51.559USD -1,547 45.47 Loss of -183 on sale
2025-02-18BUY5052.70053.030 52.997USD 2,650 44.83
2025-02-13BUY1050.70051.825 51.713USD 517 44.50
2025-02-12BUY1050.72051.000 50.972USD 510 44.38
2025-02-11BUY3050.16050.780 50.718USD 1,522 44.25
2025-02-06BUY9051.23052.460 52.337USD 4,710 43.81
2025-01-27BUY1048.48049.400 49.308USD 493 42.63
2024-12-30BUY5041.18041.970 41.891USD 2,095 42.37
2024-12-06BUY4044.67045.250 45.192USD 1,808 42.20
2024-12-05BUY1044.40045.947 45.792USD 458 42.12
2024-12-04BUY5045.47046.755 46.627USD 2,331 42.00
2024-11-29BUY5046.22047.080 46.994USD 2,350 41.52
2024-11-27BUY4046.65046.870 46.848USD 1,874 41.08
2024-11-26BUY1045.15045.400 45.375USD 454 40.89
2024-11-21BUY5043.48044.115 44.052USD 2,203 40.38
2024-11-20BUY3043.69044.120 44.077USD 1,322 40.19
2024-11-18BUY12041.42044.390 44.093USD 5,291 40.00
2024-11-12BUY8042.28045.811 45.458USD 3,637 39.85
2024-11-08BUY5042.00042.575 42.518USD 2,126 39.69
2024-11-07BUY15041.08041.470 41.431USD 6,215 39.58
2024-11-06BUY2041.09042.750 42.584USD 852 39.46
2024-10-31BUY1038.46039.470 39.369USD 394 39.18
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MIRM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1972,23412,268239,58330.1%
2025-09-1856,2894,189270,19620.8%
2025-09-1763,1962,072246,78125.6%
2025-09-1651,643737135,38638.1%
2025-09-1564,8881,194154,25142.1%
2025-09-1257,1604,688134,19842.6%
2025-09-1170,28615,334174,51140.3%
2025-09-1082,4645,085167,28149.3%
2025-09-0973,988834336,08622.0%
2025-09-0897,34013,009164,65659.1%
2025-09-0580,69216,260182,48044.2%
2025-09-0478,8564,815267,45829.5%
2025-09-03107,4136,645236,55945.4%
2025-09-0293,33713,124262,89835.5%
2025-08-29121,90448,466300,33540.6%
2025-08-281,070,514487,9471,261,34684.9%
2025-08-27178,88715,088336,54553.2%
2025-08-26162,36247,309392,10341.4%
2025-08-25152,41611,814376,25440.5%
2025-08-22239,53918,239501,02247.8%
2025-08-21102,7781,810220,35346.6%
2025-08-2065,99915,860117,61456.1%
2025-08-19109,84023,102254,29443.2%
2025-08-18143,78113,657280,96951.2%
2025-08-15143,4367,364448,89332.0%
2025-08-14135,036152253,87953.2%
2025-08-13142,03413,145401,03135.4%
2025-08-12204,95018,158529,10238.7%
2025-08-11547,43866,339931,93858.7%
2025-08-08130,75016,423382,75234.2%
2025-08-07516,88225,348928,07655.7%
2025-08-06128,256184252,66250.8%
2025-08-0578,05514157,09549.7%
2025-08-0443,79660120,84736.2%
2025-08-0152,94079107,26749.4%
2025-07-3155,0970107,01651.5%
2025-07-3043,2000115,79937.3%
2025-07-2968,7530113,92360.4%
2025-07-2836,2001954,13366.9%
2025-07-2558,369887,77266.5%
2025-07-2465,1683394,13269.2%
2025-07-23135,117183188,92271.5%
2025-07-2276,6660101,23175.7%
2025-07-2161,21138996,96863.1%
2025-07-1828,143061,65045.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy